Kirr Marbach Partners Value Fund (KMVAX) Fund Overview

Kirr Marbach Partners Value Fund (KMVAX) Financial Services Profile

Kirr Marbach Partners Value Fund (KMVAX) is an asset management firm that invests in common stocks across small, medium, and large-capitalization companies, seeking to maximize returns through strategic asset allocation. The fund maintains a diversified portfolio with at least 65% of its assets in equity securities, operating within the competitive financial services sector.

What Is the Investment Thesis for KMVAX?

Kirr Marbach Partners Value Fund (KMVAX) presents a notable research candidate due to its diversified investment approach and focus on value investing. The fund's strategy of allocating assets across small, medium, and large-cap companies allows it to capture growth opportunities across various market segments. With at least 65% of its assets invested in equity securities, KMVAX is positioned to benefit from potential market appreciation. However, the fund's performance is subject to market volatility and economic conditions. The fund's beta of 1.08 indicates that it is slightly more volatile than the market. The absence of a dividend yield may deter income-seeking investors. The fund's success hinges on its ability to identify and capitalize on undervalued investment opportunities, while effectively managing risk.

Based on FMP financials and quantitative analysis

KMVAX Key Highlights

Market capitalization of $0.11 billion indicates a relatively small fund within the asset management industry.

• Beta of 1.08 suggests the fund's volatility is slightly higher than the overall market.
• Investment strategy focuses on common stocks of companies with small, medium, and large market capitalizations.
• At least 65% of total assets are allocated to common stocks or other equity securities, emphasizing equity-focused investment.
• Absence of dividend yield may be a drawback for income-focused investors.

Who Are KMVAX's Competitors?

KMVAX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are KMVAX's Key Strengths?

Diversified investment approach across market capitalizations.

• Experienced investment team with a focus on value investing.
• Disciplined investment process with rigorous research and due diligence.
• Commitment to long-term capital appreciation.

What Are KMVAX's Weaknesses?

Relatively small market capitalization compared to larger asset managers.

• Absence of dividend yield may deter income-seeking investors.
• Performance is subject to market volatility and economic conditions.
• High beta compared to benchmark.

What Are the Key Risks for KMVAX?

Market volatility and economic downturns could negatively impact fund performance.

• Increased competition from other asset management firms could lead to lower fees and margins.
• Regulatory changes and compliance requirements could increase operating costs.
• Dependence on the investment team's ability to identify and capitalize on attractive investment opportunities.

What Are KMVAX's Competitive Advantages?

• Experienced investment team with a proven track record.
• Disciplined investment process focused on value investing.
• Diversified portfolio across market capitalizations and sectors.

What Does KMVAX Do?

Kirr Marbach Partners Value Fund (KMVAX) is an asset management firm dedicated to delivering value through strategic investments in common stocks. The fund's primary objective is to achieve long-term capital appreciation by investing in companies across the market capitalization spectrum, including small-cap (less than $1 billion), mid-cap ($1-$15 billion), and large-cap (more than $15 billion) enterprises. The fund operates under the principle of diversification, ensuring that at least 65% of its total assets are allocated to common stocks or other equity securities. KMVAX's investment strategy involves a rigorous analysis of potential investments, focusing on companies with strong fundamentals and growth potential. The fund's portfolio construction process emphasizes a balance between risk and return, aiming to generate consistent performance over time. The fund's investment decisions are guided by a team of experienced professionals who conduct in-depth research and due diligence to identify attractive investment opportunities. KMVAX competes within the broader asset management industry, facing competition from other mutual funds, hedge funds, and investment advisory firms. The fund differentiates itself through its focus on value investing and its commitment to a diversified portfolio. As of 2026, Kirr Marbach Partners Value Fund manages approximately $0.11 billion in assets.

What Products and Services Does KMVAX Offer?

• Invests in common stocks of companies with small-capitalizations (less than $1 billion).
• Invests in common stocks of companies with medium-capitalizations ($1-$15 billion).
• Invests in common stocks of companies with large-capitalizations (more than $15 billion).
• Allocates at least 65% of its total assets to common stocks or other equity securities.
• Seeks long-term capital appreciation through strategic asset allocation.
• Conducts in-depth research and due diligence to identify attractive investment opportunities.
• Manages a diversified portfolio to balance risk and return.

How Does KMVAX Make Money?

• Generates revenue through management fees charged on assets under management (AUM).
• AUM is influenced by investment performance and investor inflows/outflows.
• Expenses include investment management fees, administrative costs, and marketing expenses.

What Industry Does KMVAX Operate In?

Kirr Marbach Partners Value Fund (KMVAX) operates within the asset management industry, a sector characterized by intense competition and evolving market dynamics. The industry is influenced by factors such as interest rates, economic growth, and investor sentiment. Asset management firms compete for investor capital by offering a range of investment products and services, including mutual funds, exchange-traded funds (ETFs), and separately managed accounts. The industry is subject to regulatory oversight and compliance requirements, which can impact profitability and growth. KMVAX competes with firms like AABPX, DDDAX, EAERX, GPRIX, and IHD, each vying for market share and investor assets.

Who Are KMVAX's Key Customers?

• Individual investors seeking long-term capital appreciation.
• Institutional investors, including pension funds, endowments, and foundations.
• Financial advisors and wealth managers seeking investment solutions for their clients.

KMVAX Financials

KMVAX Latest News

No recent news available for KMVAX.

KMVAX Analyst Consensus

KMVAX MoonshotScore

What Investors Ask About Kirr Marbach Partners Value Fund (KMVAX) — Financials

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources